Sigma-Aldrich Ireland
Ireland Updated 9 July 2026
Sigma-Aldrich Ireland is an API manufacturer based in Ireland. It holds 7 active US drug master files across a filed portfolio of 7 molecules. Its most recent recorded inspection, by US FDA, closed on 26 August 2022 as VAI.
1
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
5 of 5 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 26 August 2022 VAI US FDA
- 12 October 2018 VAI US FDA
- 19 February 2016 NAI US FDA
- 2 November 2012 NAI US FDA
- 12 March 2009 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Ireland, Ireland | 3002807302 |
What they file, and where
| Molecule | Regulators | Docs |
| Benzyl Alcohol | US FDA | 1 |
| Brompheniramine | US FDA | 1 |
| Clomipramine | US FDA | 1 |
| Doxylamine | US FDA | 1 |
| Ethanol | US FDA | 1 |
| Nortriptyline | US FDA | 1 |
| Sodium Benzoate | US FDA | 1 |
Also appears on these molecule pages
Comparing suppliers?
Choose your molecules and target markets. Sigma-Aldrich Ireland comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 26 August 2022.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability